Johnson & Johnson Other Current Assets

The latest other current assets for JNJ is $4.8B as of June 2026. That compares with $4.4B in the prior-year period — up 10.7% year over year. Investors often review this figure alongside Johnson & Johnson's historical trend and sector peers before judging valuation or financial health.

Over the past year, JNJ's other current assets moved from $4.4B to $4.8B — a 10.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Johnson & Johnson's operating scale or balance-sheet position.

A other current assets figure of $4.8B for JNJ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting JNJ's other current assets ($4.8B), review year-over-year change from $4.4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Johnson & Johnson's other current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.